Enhancement of B7-1 (CD80) expression on B-lymphoma cells by irradiation

Immunology

Volumn 96, Issue 4, 1999, Pages 642-648

  Seo, A ^a   Ishikawa, F ^a   Nakano, H ^a   Nakazaki, H ^a   Kobayashi, K ^a   Kakiuchi, T ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; INTERLEUKIN 2; OVALBUMIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IRRADIATION; LYMPHOCYTE ACTIVATION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; ANTIGENS, NEOPLASM; BLOTTING, NORTHERN; DOSE-RESPONSE RELATIONSHIP, RADIATION; INTERLEUKIN-2; LYMPHOMA, B-CELL; MICE; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032948986     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00720.x     Document Type: Article

References (40)

1. 1. Mueller D.L., Jenkins M.K. & Schwartz R.H. (1989) Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7, 445.
2. 2. Linsley P.S. & Ledbetter J.A. (1993) The role of CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11, 191.
3. 3. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K. & Ledbetter J.A. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173, 721.
4. 4. Freeman G.J., Gray G.S., Gimmi C.D. et al. (1991) Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 174, 625.
5. 5. Galvin F., Freeman G.J., Razi-Wolf Z. et al. (1992) Murine B7 antigen provides a sufficient costimulator signal for antigen-specific and MHC-restricted T cell activation. J Immunol 149, 3802.
6. 6. Baskar S., Clements V.K., Climcher L.H., Nabavi N. & Ostrand-Rosenberg S. (1996) Rejection of MHC class II-transfected tumor cells requires induction of B7-1 and/or B7-2 costimulatory molecules. J Immunol 156, 3821.
7. 7. Matulonis U., Dosiou C., Freeman G. et al. (1996) B7-1 is superior to B7-2 costimulation in the induction of and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 156, 1126.
8. 8. Gajewski T.F., Fallarino F., Uyttenhove C. & Boon T. (1996) Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor. Superiority of B7-1 over B7-2 for active tumor immunization. J Immunol 156, 2909.
9. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J Exp Med 181, 619.
10. 10. Lenschow D.J., Sperling A.I., Cooke M.P. et al. (1994) Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 153, 1990.
11. 11. Kozono Y., Abe R., Kozono H., Kelly R.G., Azuma T. & Holers V.M. (1998) Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine B cells. J Immunol 160, 1565.
12. 12. Laihia J.K. & Jansen C.T. (1997) Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-stimulating irradiation. Eur J Immunol 27, 984.
13. 13. Aoi T., Nakano H., Tanaka Y. & Kakiuchi T. (1997) Enhancement of antigen-presenting ability of B lympoma cells by partial inhibition of protein synthesis through inducing B7-1 expression. Immunology 91, 212.
14. 14. Inobe M., Linsley P.S., Ledhetter J.A., Nagai Y., Tamakoshi M. & Uede T. (1994) Identification of an alternatively spliced form of the murine homologue of B7. Biochem Biophys Res Commun 200, 443.
15. 15. Cleveland D.W., Lopata M.A., MacDonald R.J., Cowan N.J., Rutter W.J. & Kirshner M.W. (1980) Number and evolutionary conversion of α-and β-tubulin and cytoplasmic β-and γ-actin genes using specific cloned cDNA probes. Cell 20, 90.
16. 16. Bhattacharya A., Dorf M.E. & Springer T.A. (1981) A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplications. J Immunol 127, 2488.
17. 17. Hathcock K.S., Laszlo G., Dickler H.B., Bradshaw J., Linsley P. & Hodes R.J. (1993) Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (Washington DC) 262, 905.
18. 18. Sarmiento M., Dialynas D.P., Lancki D.W. et al. (1982) Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol Rev 68, 135.
19. 19. Dialynas D.P., Quan Z.S., Wall K.A. et al. (1983) Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GKL5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131, 2445.
20. 20. Takei F. (1985) Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 134, 1403.
21. 21. Razi-Wolf Z., Freeman G.J., Galvin F., Benacerraf B., Nadler L. & Reiser H. (1992) Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoncal exudate cells. Proc Natl Acad Sci USA 89, 4210.
22. 22. Powers G.D., Faherty D.A., Connaughton S.E. et al. (1994) Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody. Cell Immunol 153, 298.
23. 23. Kakiuchi T., Taira S. & Nariuchi H. (1986) B cells as antigen-presenting cells: antibody production in vitro against a T-cell dependent antigen. Cell Immunol 100, 515.
24. 24. Kakiuchi T., Watanabe M., Hozumi N. & Nariuchi H. (1990) Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J Immunol 145, 1653.
25. 25. Kokuho T., Nariuchi H., Gyotoku Y. & Kakiuchi T. (1995) Role of newly synthesized MHC class II molecules in antigen-specific antigen presentation by B cells. Immunobiology 193, 42.
26. 26. Chomczynski P. & Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
27. 27. Ostergaard H.L. & Clark W.R. (1989) Evidence for multiple lytic pathway used by cytotoxic T lymphocytes. J Immunol 143, 2120.
28. 28. Abdel-Wahab Z., Dar M.M., Hester D. et al. (1996) Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-γ gene-mediated melanoma cells. Cell Immunol 171, 246.
29. 29. Chen J.C., Davis B.H., Leon M.A. & Leong L. (1997) Gamma radiation induces CD69 expression on lymphocytes. Cytometry 30, 304.
30. 30. Haimovitz-Friedman A., Vlodavsky I., Chaudhuri A., Witte L. & Fuks Z. (1991) Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51, 2552.
31. 31. Gibbons D.C. & Evans T.G. (1996) CD69 expression after antigenic stimulation. Cytometry 23, 260.
32. 32. Fong T.C., Wu Y. & Kipps T.J. (1996) Identification of a promoter element that regulates tissue-specific expression of the human CD80 (B7.1 ) gene. J Immunol 157, 4442.
33. 33. Zhao J.-L., Freeman G.J., Gray G.S., Nadler L.M. & Glimcher L.H. (1996) A cell type-specific enhancer in the human B7.1 gene regulated by NF-κB. J Exp Med 183, 777.
34. 34. Raju U., Lu R., Noel F., Gumin G.J. & Tofilon P.J. (1997) Failure of a second X-ray dose to activate nuclear factor kappaB in normal rat astrocytes. J Biol Chem 272, 24624.
35. 35. Nabavi N., Freeman G.J., Gault A., Godfrey D., Nadler L.M. & Glimcher L.H. (1992) Signaling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360, 266.
36. 36. Watts T.H., Alaverdi N., Wade W.F. & Linsley P.S. (1993) Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction. J Immunol 150, 2192.
37. 37. Ranheim E.A. & Kipps T.J. (1995) Tumor necrosis factor-α facilitates induction of CD8O (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 161, 226.
38. 38. Pechhold K., Patterson N.B., Craighead N., Lee K.P., June C.H. & Harlan D.M. (1977) Inflammatory cytokines IFN-γ plus TNF-α induce regulated expression of CD80 (B7) but not CD86 (B7): on murine fibroblasts. J Immunol 158, 4921.
39. 39. Lenschow D.L., Sperling A.I., Cooke M.P. et al. (1994) Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 153, 1990.
40. 40. Kalechman Y. & Sredni B. (1996) Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulalory molecules. Role in the antitumoral effect of AS101. J Immunol 157, 589.